Psychiatric treatment of persons with HIV/AIDS: an HIV-psychiatry consensus survey of current practices

Oliver Freudenreich; Harold W Goforth; Kelly L Cozza; Matthew J Mimiaga; Steven A Safren; Grace Bachmann; Mary Ann Cohen

doi:10.1176/appi.psy.51.6.480

Psychiatric treatment of persons with HIV/AIDS: an HIV-psychiatry consensus survey of current practices

Oliver Freudenreich, Harold W Goforth, Kelly L Cozza, Matthew J Mimiaga, Steven A Safren, Grace Bachmann, Mary Ann Cohen

Psychiatry

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Abstract

BACKGROUND: Only sparse evidence from controlled clinical trials is available to guide the psychiatric treatment of persons with HIV/AIDS.

OBJECTIVE: The authors assessed and determined current treatment trends in AIDS psychiatry.

METHOD: Members of the Organization of AIDS Psychiatry (OAP) participated in a web-based survey.

RESULTS: Of 159 members, 62 (39%) responded to the survey. Consensus emerged regarding first-line treatment for depression (escitalopram/citalopram), for psychosis and secondary mania (quetiapine), and for anxiety (clonazepam).

CONCLUSION: Consensus statements can serve as a preliminary step toward providing some standardization of care for persons with HIV/AIDS.

Original language	English
Pages (from-to)	480-8
Number of pages	9
Journal	Psychosomatics
Volume	51
Issue number	6
DOIs	https://doi.org/10.1176/appi.psy.51.6.480
State	Published - 2010

Keywords

Acquired Immunodeficiency Syndrome/psychology
Anxiety/drug therapy
Confidence Intervals
Depression/drug therapy
HIV Infections/psychology
Humans
Mental Disorders/drug therapy
Practice Patterns, Physicians'/statistics & numerical data
Psychotic Disorders/drug therapy
Surveys and Questionnaires

Access to Document

10.1176/appi.psy.51.6.480

Cite this

@article{bbf4073fdc074d7fa31b2ea8ed421284,

title = "Psychiatric treatment of persons with HIV/AIDS: an HIV-psychiatry consensus survey of current practices",

abstract = "BACKGROUND: Only sparse evidence from controlled clinical trials is available to guide the psychiatric treatment of persons with HIV/AIDS.OBJECTIVE: The authors assessed and determined current treatment trends in AIDS psychiatry.METHOD: Members of the Organization of AIDS Psychiatry (OAP) participated in a web-based survey.RESULTS: Of 159 members, 62 (39%) responded to the survey. Consensus emerged regarding first-line treatment for depression (escitalopram/citalopram), for psychosis and secondary mania (quetiapine), and for anxiety (clonazepam).CONCLUSION: Consensus statements can serve as a preliminary step toward providing some standardization of care for persons with HIV/AIDS.",

keywords = "Acquired Immunodeficiency Syndrome/psychology, Anxiety/drug therapy, Confidence Intervals, Depression/drug therapy, HIV Infections/psychology, Humans, Mental Disorders/drug therapy, Practice Patterns, Physicians'/statistics & numerical data, Psychotic Disorders/drug therapy, Surveys and Questionnaires",

author = "Oliver Freudenreich and Goforth, {Harold W} and Cozza, {Kelly L} and Mimiaga, {Matthew J} and Safren, {Steven A} and Grace Bachmann and Cohen, {Mary Ann}",

year = "2010",

doi = "10.1176/appi.psy.51.6.480",

language = "English",

volume = "51",

pages = "480--8",

journal = "Psychosomatics",

issn = "0033-3182",

publisher = "American Psychiatric Publishing Inc.",

number = "6",

}

TY - JOUR

T1 - Psychiatric treatment of persons with HIV/AIDS

T2 - an HIV-psychiatry consensus survey of current practices

AU - Freudenreich, Oliver

AU - Goforth, Harold W

AU - Cozza, Kelly L

AU - Mimiaga, Matthew J

AU - Safren, Steven A

AU - Bachmann, Grace

AU - Cohen, Mary Ann

PY - 2010

Y1 - 2010

N2 - BACKGROUND: Only sparse evidence from controlled clinical trials is available to guide the psychiatric treatment of persons with HIV/AIDS.OBJECTIVE: The authors assessed and determined current treatment trends in AIDS psychiatry.METHOD: Members of the Organization of AIDS Psychiatry (OAP) participated in a web-based survey.RESULTS: Of 159 members, 62 (39%) responded to the survey. Consensus emerged regarding first-line treatment for depression (escitalopram/citalopram), for psychosis and secondary mania (quetiapine), and for anxiety (clonazepam).CONCLUSION: Consensus statements can serve as a preliminary step toward providing some standardization of care for persons with HIV/AIDS.

AB - BACKGROUND: Only sparse evidence from controlled clinical trials is available to guide the psychiatric treatment of persons with HIV/AIDS.OBJECTIVE: The authors assessed and determined current treatment trends in AIDS psychiatry.METHOD: Members of the Organization of AIDS Psychiatry (OAP) participated in a web-based survey.RESULTS: Of 159 members, 62 (39%) responded to the survey. Consensus emerged regarding first-line treatment for depression (escitalopram/citalopram), for psychosis and secondary mania (quetiapine), and for anxiety (clonazepam).CONCLUSION: Consensus statements can serve as a preliminary step toward providing some standardization of care for persons with HIV/AIDS.

KW - Acquired Immunodeficiency Syndrome/psychology

KW - Anxiety/drug therapy

KW - Confidence Intervals

KW - Depression/drug therapy

KW - HIV Infections/psychology

KW - Humans

KW - Mental Disorders/drug therapy

KW - Practice Patterns, Physicians'/statistics & numerical data

KW - Psychotic Disorders/drug therapy

KW - Surveys and Questionnaires

U2 - 10.1176/appi.psy.51.6.480

DO - 10.1176/appi.psy.51.6.480

M3 - Article

C2 - 21051679

SN - 0033-3182

VL - 51

SP - 480

EP - 488

JO - Psychosomatics

JF - Psychosomatics

IS - 6

ER -